Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival
- 1 October 1994
- journal article
- Published by Elsevier in Human Pathology
- Vol. 25 (10), 1075-1083
- https://doi.org/10.1016/0046-8177(94)90068-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Oncogenes in Gynecological TumorsPublished by Springer Nature ,1992
- Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells.Molecular and Cellular Biology, 1991
- Genetic Mechanisms of Tumor Suppression by the Human p53 GeneScience, 1990
- Oncogene alterations in endometrial carcinomaGynecologic Oncology, 1990
- Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53Science, 1990
- Tumor Suppressor Genes: The Puzzle and the PromiseScience, 1989
- Flow cytometric DNA analysis of stage I endometrial carcinomaGynecologic Oncology, 1989
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981